DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

B & A Limited — Disclosure under SEBI Takeover Regulations

NSE 51 min ago·24 Sept 2026, 6:59 am

B & A

B & A Limited has disclosed that Siemen Syntex Private Limited has filed a copy of disclosures under Regulation 29(1) of the SEBI (SAST) Regulations, 2011. This regulatory filing is a standard requirement for any entity making a significant investment in a company, such as acquiring a stake above a certain threshold.

For investors, this disclosure signals that Siemen Syntex is actively building a position in B & A Limited. It suggests a potential change in ownership structure or significant influence over the company's future, which can be a key development for retail shareholders to monitor.

Investors should watch for the specific percentage of shares acquired by Siemen Syntex. Further announcements regarding the completion of the transaction or any changes in the shareholding pattern will provide more clarity on the impact of this development on the stock.